Nov . 19, 2026 16:32 Back to list
Human Papillomavirus (HPV) is a group of viruses that can infect the skin and mucous membranes. Different HPV genotypes have different clinical significance, and certain high-risk types are closely associated with cervical precancerous lesions and cervical cancer. Therefore, accurate HPV genotype identification plays an important role in cervical health screening and clinical assessment.
The Cowingene HPV 28 Genotyping Detection Kit (Lyophilized) is a molecular diagnostic product designed to support the detection and differentiation of HPV genotypes through PCR-based technology. Its lyophilized reagent format provides an alternative to conventional liquid reagent presentation, offering potential advantages in reagent handling, storage, and testing workflow, depending on the validated product specifications.
As a specialized manufacturer of molecular POCT in vitro diagnostic reagents, Cowin Gene focuses on developing innovative diagnostic solutions for healthcare professionals and clinical laboratories. With a professional team and a commitment to technological innovation, the company aims to make molecular diagnostics more efficient, accessible, and intelligent.

HPV genotyping provides more detailed information than general HPV screening because it identifies specific HPV types rather than simply reporting whether HPV genetic material is present.
The Cowingene HPV 28 Genotyping Detection Kit (Lyophilized) is designed to detect and differentiate 28 HPV genotypes using molecular diagnostic technology. By targeting specific viral DNA sequences, PCR-based testing helps healthcare professionals obtain genotype-related information for clinical evaluation.
The key value of HPV genotyping includes:
Specific Genotype Identification
Genotyping helps distinguish individual HPV types included in the assay's validated detection panel, providing more detailed molecular information.
Molecular Detection Technology
PCR technology amplifies specific DNA sequences, supporting the detection of targeted genetic material in clinical samples.
Clinical Screening Support
HPV genotype information can be used alongside cervical cytology, medical history, and other clinical findings to support appropriate screening and follow-up strategies.
Comprehensive Molecular Testing
A multi-genotype detection approach can provide broader HPV-related information within a single validated testing workflow.
For hospitals, diagnostic laboratories, and healthcare institutions, molecular HPV genotyping can be a valuable component of modern cervical health management.
Lyophilization, also known as freeze-drying, is a technology used to remove water from prepared materials under controlled conditions. In molecular diagnostics, lyophilized reagent formulations are developed to improve reagent presentation and support specific storage and transportation requirements.
Compared with liquid reagent formats, lyophilized molecular diagnostic reagents may offer several practical advantages when supported by appropriate formulation and validation.
Removing moisture through a controlled freeze-drying process can help improve the stability of certain reagent formulations. This is particularly relevant for molecular diagnostic products that contain sensitive biological or biochemical components.
Actual stability depends on the reagent formulation, packaging system, storage conditions, and validated shelf-life data.
Lyophilized reagents may provide greater flexibility in storage and transportation compared with certain liquid formulations. This can be beneficial for distributors and diagnostic product suppliers serving different geographical markets.
However, transportation temperature requirements and storage conditions must always follow the manufacturer's instructions.
A pre-prepared lyophilized reagent format can help standardize reagent handling procedures. Depending on the product design, users may need to perform reconstitution or other preparation steps before testing.
Clear operating instructions are important for maintaining workflow consistency and minimizing preparation errors.
Standardized reagent formulations can contribute to consistent molecular diagnostic workflows. When combined with validated PCR instruments, sample preparation procedures, and quality control measures, lyophilized reagents can support routine laboratory testing.
Cowin Gene specializes in developing and manufacturing molecular POCT in vitro diagnostic reagents. The company focuses on providing practical testing solutions that address the needs of healthcare professionals and diagnostic institutions.
Its core product advantages include the following.
Timely diagnostic information is essential in many clinical environments. Cowin Gene's molecular POCT products are developed with a focus on efficient detection workflows, helping improve testing convenience and support timely clinical assessment.
The actual detection time depends on the specific product, instrument, sample preparation, and operating procedure.
A user-friendly testing process is important for improving operational efficiency. Cowin Gene emphasizes convenient operation procedures in its molecular diagnostic product development, helping healthcare professionals perform testing through standardized workflows.
Sensitivity is an important consideration when evaluating molecular diagnostic reagents. PCR technology enables the amplification of specific target DNA sequences, supporting the detection of genetic material in clinical samples.
Cowin Gene focuses on high-sensitivity detection performance as part of its product development strategy. Specific analytical performance should be evaluated according to the corresponding product validation data.
With a professional team and an innovative development philosophy, Cowin Gene continues to explore molecular diagnostic technologies and develop solutions for different pathogen detection requirements.
The company aims to make molecular testing more accessible and practical across a variety of healthcare application scenarios.
HPV genotyping is an important molecular testing approach in cervical health screening. Identifying individual HPV genotypes can provide additional information to support clinical assessment and follow-up.
Cervical Cancer Screening Support
High-risk HPV infections are associated with cervical cancer development. HPV testing is an important component of many cervical screening strategies, and genotype identification can provide additional information for risk-based clinical management.
Clinical Diagnostic Laboratories
Molecular diagnostic laboratories require reliable testing methods for detecting specific viral genetic sequences. PCR-based HPV genotyping kits can support standardized laboratory testing procedures.
Hospital and Healthcare Institutions
Hospitals and healthcare facilities can incorporate validated HPV molecular testing into broader cervical health assessment programs.
Women's Health Management
HPV genotyping provides useful information that can support women's health management, helping healthcare professionals evaluate test results alongside other clinical findings.
It is important to emphasize that a positive HPV result does not independently indicate cervical cancer. Appropriate interpretation and follow-up should be determined by qualified healthcare professionals.
In addition to HPV genotyping detection solutions, Cowin Gene develops PCR-based molecular POCT diagnostic kits for detecting various pathogens.
Its core product portfolio focuses on three major pathogen categories:
By focusing on PCR-based molecular diagnostic technology, Cowin Gene aims to provide convenient testing solutions for different healthcare requirements.
The company's product development strategy combines molecular diagnostic expertise, reagent innovation, and practical testing considerations to address the growing demand for accessible pathogen detection.
Choosing a molecular diagnostic reagent supplier requires consideration of more than individual product specifications. Buyers and distributors also need to evaluate the manufacturer's technical expertise, product portfolio, development capabilities, and long-term cooperation potential.
Cowin Gene offers several advantages for potential business partners.
Specialized Molecular POCT Manufacturing
The company focuses on the development and manufacturing of molecular POCT in vitro diagnostic reagents, building its expertise around PCR-based diagnostic technologies.
Professional Technical Team
A professional team supports the company's ongoing product development and technological innovation, helping create molecular diagnostic solutions for different testing needs.
Multiple Pathogen Detection Applications
Its core product portfolio covers molecular testing solutions for viruses, bacteria, and fungi, providing opportunities for distributors to expand their diagnostic product offerings.
Commitment to Diagnostic Innovation
Cowin Gene is committed to advancing healthcare management through more efficient, accessible, and intelligent molecular diagnostic products.
Focus on Practical Testing Needs
Rapid detection time, convenient operation procedures, and high-sensitivity detection performance are important considerations throughout the company's molecular POCT product development.
For international distributors, medical product suppliers, and diagnostic industry partners, Cowin Gene aims to become a trusted partner in the molecular diagnostics field.
An HPV 28 Genotyping Detection Kit is a molecular diagnostic product designed to identify HPV genetic material and differentiate the genotypes included in its validated detection panel.
Lyophilized reagents are freeze-dried formulations designed to reduce moisture content, while liquid reagents are supplied in a liquid formulation. Their storage requirements, preparation procedures, and stability characteristics depend on the specific product design.
Potential advantages include improved formulation stability, convenient reagent presentation, and greater flexibility in storage and transportation. These benefits depend on product-specific validation and packaging.
PCR-based molecular diagnostic technology is used to amplify specific DNA sequences and support the identification of targeted HPV genotypes.
Different HPV genotypes have different clinical significance. Genotyping provides more detailed information than general HPV screening and can support clinical risk assessment when combined with other examination results.
Hospitals, clinical laboratories, diagnostic institutions, and qualified healthcare facilities may use validated HPV molecular diagnostic kits as part of their cervical health screening and testing services.
The Cowingene HPV 28 Genotyping Detection Kit (Lyophilized) combines PCR-based molecular diagnostic technology with a lyophilized reagent format to support HPV genotype identification. It is designed to address the demand for detailed molecular testing and convenient reagent handling in modern diagnostic environments.
With its specialized focus on molecular POCT in vitro diagnostic reagents, professional technical team, and innovation-driven development approach, Cowin Gene continues to provide diagnostic solutions for detecting viruses, bacteria, and fungi.
For medical distributors, clinical laboratories, and healthcare industry partners seeking molecular diagnostic products, Cowin Gene offers a growing portfolio focused on rapid detection, convenient operation, and high-sensitivity molecular testing.
Related PRODUCTS
Meet COWIN GENE at WHX Bangkok 2026!
NewsJun.09,2026Supporting Ebolavirus Surveillance with Real-time PCR Detection
NewsMay.27,20267 Days To Go Until Whx Lagos 2026!
NewsMay.26,2026Cowingene STI Multiplex Pro Detection Kit-STI21 (Liquid): Advanced Multiplex PCR Diagnostic Solution
NewsNov.19,2026Cowingene Respiratory Pathogen Panel Pro Detection Kit (Liquid): Advanced Molecular Diagnostics for Respiratory Infections
NewsNov.19,2026Cowingene HPV Genotyping Detection Kit - HPV-40 Panel (Liquid): Comprehensive Molecular Testing with PCR Technology
NewsNov.19,2026